There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Medical weight loss is a personalized, medically ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight.

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...

By Don Thompson for KFF Health News. Broadcast version by Suzanne Potter for California News Service reporting for the KFF ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...

An Australian-led study suggests dietary intake and nutrition are being ignored in global studies of GLP-1s, which could result in malnutrition, even scurvy.

PepsiCo CEO Ramon Laguarta will spend 2026 executing on a bold reinvention of the beverage and snack giant. "This is part of ...